Joint webinar on GOLD COPD GUIDELINES, Next Saturday, 12 August 2023 from 8:00 to 9:10 (CEST/UTC+2)
GOLD Scientific Committee responses the five letters received in relation to the recent publication of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023.
COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.
The use of biologic therapies, including monoclonal antibodies, has revolutionized the treatment of many human diseases.
Senescencia y progresión a daño orgánico en las enfermedades crónicas inmunomediadas: ¿Podemos prevenirlo?
It is now well established that there are different life-long lung function trajectories in the general population, and that some are associated with better or worse health outcomes.
En la XXXV edición de las Jornadas Técnicas del Institut Guttmann expertos en neurorrehabilitación, en metodología XPA, en humanización y en gestión aportaron conocimientos, ideas y buenas prácticas para humanizar la gestión y la atención sanitaria en las organizaciones asistenciales.
In this expert interview, MeiLan K Han and Alvar Agustí discuss the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 executive report, which proposes a new definition for COPD and covers the latest updates in its diagnosis, management, and prevention.
Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).
The term GETomics has been recently proposed to illustrate that human health and disease are actually the final outcome of many dynamic, interacting and cumulative gene environment interactions that occur through the lifetime of the individual.
